Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-28 @ 10:58 PM
Study NCT ID:
NCT00003494
Status:
TERMINATED
Last Update Posted:
2018-01-31
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer
Sponsor:
Burzynski Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000066533
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None